Detection of antibodies to Coccidioides immitis by enzyme immunoassay

M Zartarian1, E M Peterson, L M de la Maza

  • 1Department of Pathology, University of California Irvine, Medical Center, Orange 92668-4805, USA.

Insights

The Meridian Premier Coccidioides enzyme immunoassay (MPC-EIA) accurately detects Coccidioides antibodies in serum and cerebrospinal fluid. This diagnostic tool shows high sensitivity and specificity, making it reliable for identifying coccidioidomycosis.

Area of Science:

  • Medical Diagnostics
  • Immunology
  • Mycology

Background:

  • Coccidioidomycosis diagnosis relies on serologic tests.
  • Conventional methods like complement fixation (CF) can be time-consuming.
  • Need for rapid and accurate diagnostic tools is crucial.

Purpose of the Study:

  • Evaluate the Meridian Premier Coccidioides enzyme immunoassay (MPC-EIA) performance.
  • Compare MPC-EIA results with conventional serologic tests (CF and TP).
  • Assess diagnostic accuracy, including sensitivity, specificity, and predictive values.

Main Methods:

  • Tested 226 specimens (160 serum, 66 CSF) using MPC-EIA.
  • Compared MPC-EIA results against complement-fixing (CF) and tube precipitin (TP) antibody tests.
  • Analyzed agreement, sensitivity, specificity, and predictive values after excluding indeterminate/anticomplementary samples.

Main Results:

  • MPC-EIA demonstrated 99% agreement with CF tests after exclusions.
  • Achieved 98% specificity and 100% sensitivity against CF.
  • Positive and negative predictive values were 96% and 100%, respectively.

Conclusions:

  • MPC-EIA is a highly accurate and reliable method for diagnosing coccidioidomycosis.
  • The assay shows excellent correlation with conventional serologic tests.
  • MPC-EIA offers a valuable alternative for Coccidioides antibody detection in clinical settings.